Virtual Library

Start Your Search

  • WCLC 2016

    17th World Conference on Lung Cancer

    Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria

    Presentation Date(s):  
    • Dec 4 - 7, 2016
    • Total Presentations: 2466

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    OA05 - Treatment Advances in SCLC

    • Type: Oral Session
    • Track: SCLC/Neuroendocrine Tumors
    • Presentations: 8
    • Moderators:A. Ardizzoni
    • Coordinates: 12/05/2016, 14:20 - 15:50, Strauss 2
    • +

      OA05.03 - Single-Agent Rovalpituzumab Tesirine, a Delta-Like Protein 3 (DLL3)-Targeted Antibody-Drug Conjugate (ADC), in Small-Cell Lung Cancer (SCLC)

      14:40 - 14:50  |  Author(s): D.R. Spigel

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P1.05 - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Early Stage NSCLC
    • Presentations: 79
    • Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P1.05-047 - Early Mortality in Patients with Non-Small Cell Lung Cancer Undergoing Adjuvant Chemotherapy

      14:30 - 14:30  |  Author(s): D. Morgensztern

      • Abstract

      Loading...

  • +

    P1.07 - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: SCLC/Neuroendocrine Tumors
    • Presentations: 55
    • Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P1.07-035 - Circulating Cell-Free Tumor DNA (cfDNA) Testing in Small Cell Lung Cancer

      14:30 - 14:30  |  Author(s): D. Morgensztern

      • Abstract

      Loading...

  • +

    MA08 - Treatment Monitoring in Advanced NSCLC

    • Type: Mini Oral Session
    • Track: Advanced NSCLC
    • Presentations: 12
    • Moderators:R. Perez-Soler
    • Coordinates: 12/06/2016, 11:00 - 12:30, Lehar 3-4
    • +

      MA08.06 - Impact of Depth of Response (DpR) on Survival in Patients with Advanced NSCLC Treated with First-Line Chemotherapy

      11:36 - 11:42  |  Author(s): D. Morgensztern

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA09 - Immunotherapy Combinations

    • Type: Mini Oral Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 12
    • Moderators:M. Sebastian
    • Coordinates: 12/06/2016, 14:20 - 15:50, Strauss 2
    • +

      MA09.06 - Viagenpumatucel-L Bolsters Response to Nivolumab Therapy in Advanced Lung Adenocarcinoma: Preliminary Data from the DURGA Trial

      14:56 - 15:02  |  Author(s): D. Morgensztern

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MA09.09 - First-In-Human Phase 1 Study of ABBV-399, an Antibody-Drug Conjugate (ADC) Targeting C-Met, in Patients with Non-Small Cell Lung Cancer (NSCLC)

      15:20 - 15:26  |  Author(s): E. Angevin

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.03a - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 72
    • Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P2.03a-002 - Patterns of Chemotherapy Use and Overall Survival (OS) of Patients with Stage IV Squamous Lung Cancer (SCC)

      14:30 - 14:30  |  Author(s): S.N. Waqar

      • Abstract

      Loading...

    • +

      P2.03a-030 - nab-Paclitaxel/Carboplatin Induction Therapy in Squamous (SCC) NSCLC: Interim Quality of Life (QoL) Results From ABOUND.sqm

      14:30 - 14:30  |  Author(s): M. Thomas

      • Abstract

      Loading...